{{Rsnum
|rsid=1805414
|Gene=PARP1
|Chromosome=1
|position=226385663
|Orientation=minus
|GMAF=0.4628
|Gene_s=PARP1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 15.9 | 42.5 | 41.6
| HCB | 62.7 | 32.1 | 5.2
| JPT | 62.8 | 32.7 | 4.4
| YRI | 35.6 | 47.9 | 16.4
| ASW | 26.3 | 38.6 | 35.1
| CHB | 62.7 | 32.1 | 5.2
| CHD | 70.6 | 24.8 | 4.6
| GIH | 19.8 | 42.6 | 37.6
| LWK | 39.4 | 44.0 | 16.5
| MEX | 25.9 | 48.3 | 25.9
| MKK | 17.3 | 48.7 | 34.0
| TSI | 7.9 | 39.6 | 52.5
| HapMapRevision=28
}}{{PMID Auto
|PMID=23803078
|Title=The C Allele of a Synonymous SNP (rs1805414, Ala284Ala) in PARP1 is a Risk Factor for Susceptibility to Breast Cancer in Saudi Patients
}}

{{PMID Auto
|PMID=19604089
|Title=Pharmacodynamic genes do not influence risk of neutropenia in cancer patients treated with moderately high-dose irinotecan.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}